Position in LPCN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$199,014
-$1,005 QoQ
Shares Held
24,908
-0.0% QoQ
Ownership
0.302%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LPCN Over Time
Shares Held
Position Value (USD)
Derivatives in LPCN
reported options exposure · as of Dec 31, 2023CallValue
$243,009
CallShares
87,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,162,367,415 across 355 Biotechnology names. LPCN ranks #287 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in LPCN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $199,014 | 24,908 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $200,019 | 24,909 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $133,268 | 46,761 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $145,419 | 46,019 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $123,955 | 38,980 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $122,024 | 25,005 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $112,285 | 25,008 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $206,008 | 25,001 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $310,268 | 59,667 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $157,915 | 56,601 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $243,009 | 87,100 | Call | Defined | 2024-02-14 | |
| 2023-09-30 | $75,480 | 25,329 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $259,856 | 87,200 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $55,409 | 10,994 | Shares | Defined | 2023-08-11 | |
| 2023-06-30 | $439,488 | 87,200 | Call | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||